NOAEL Studies
Active Ingredient
Ensulizole NOAEL Studies
INCI: PHENYLBENZIMIDAZOLE SULFONIC ACID
CAS: 27503-81-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | NOAEL | 1000 | mg/kg bw/day | rat | oral | 91 day | Subchronic | SCCP; E.Bomhard et al. (Bayer AG, Institute of Toxicology):'Novantisolsaeure – Subchronic Toxicity Study in Rats'. Report no. 7780. 06-09-78 |
SCCS Opinion 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.125 | mg/kg | rat | oral | 90-day | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =4 | % | rat | oral | 90-day | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =40 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.18 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw | rat | oral | - | NOAEL study | p.21 |
ToxValDB GESTIS DNEL 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB GESTIS DNEL | DNEL systemic | =7 | mg/m3 | Human | inhalation | - | Toxicity Value | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/6543dd69e4b045b9ff7cd87e; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://www.dguv.de/ifa/gestis/gestis-dnel-liste/index-2.jsp; STUDY_GROUP=GESTIS DNEL:15634079:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_ef0426372325e7c97762b2bd6dfcd78a |
Regulatory source 9 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 200 | mg/kg bw | rat | oral | 13 week | - | p.29 |
| Regulatory source | - | 1000 | mg/kg bw | rat | oral | - | - | p.21 |
| Regulatory source | - | 1000 | mg/kg bw/day | rat | oral | 90-day | - | p.29 |
| Regulatory source | - | 1000 | mg/kg bw | rat | oral | 90-day | - | p.29 |
| Regulatory source | dermal absorption | =0.125 | mg/kg | rat | oral | 90-day | dermal absorption | p.29 |
| Regulatory source | dermal absorption | 4 | % | rat | oral | 90-day | dermal absorption | p.29 |
| Regulatory source | dermal absorption | =40 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.29 |
| Regulatory source | dermal absorption | 200 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.29 |
| Regulatory source | genotoxicity | 1000 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.18 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 9YQ9DI1W42 | UNII | - | - | - | chemical | - |